This site requires cookies for account access and purchasing. It looks like cookies are disabled in your browser. To find out more about our cookie usage policy click here then to find out about changing your browser cookie settings click here (This link opens in a window).

This site requires cookies for account access and purchasing. You can review our use of cookies in our Cookie Policy, or Accept and Close this bar now.

This site requires cookies for account access and purchasing. It looks like cookies are disabled in your browser. To find out more about our cookie usage policy click here then to find out about changing your browser cookie settings click here (This link opens in a window).

This site requires cookies for account access and purchasing. You can review our use of cookies in our Cookie Policy, or Accept and Close this bar now.

Antithrombotic Therapy in Prevention of Ischemic Stroke

Antithrombotic Therapy in Prevention of Ischemic Stroke
Our Price: €12.20
ISBN/EAN: 9780195394320
AvailabilityOUT OF STOCK - Delivery in 5-10 working days
Publisher: OXFORD UNIVERSITY PRESS
Pub. Date: August 19 2010
Author: BECKER
Format: Paperback
Save wishlist

Stroke is the most common cause of adult mortality in the United States. Antithrombotic agents form the mainstay of stroke prevention. Aspirin produces a modest reduction in the risk of second stroke and transient ischemic attack (TIA, mini-stroke) and is widely recommended for initial therapy. The thienopyridines (Ticlid) and clopodogrel (Plavix) are alternatives for secondary prevention in patients who do not respond to or cannot take aspirin. They are no more effective than aspirin and have been associated with thrombotic thrombocytopenic purpura. The combination of aspirin and extended-release dipyridamole (Aggrenox) has several mechanisms of action and an additive effect on reducing stroke risk compared with either agent alone. A 2-fold increase in risk reduction and favorable safety profile suggest that the combination can serve as first-line prophylaxis against a second stroke. This volume, as part of the Oxford American Pocket Note series, provides the clinician with up-to-date information on the guidelines, and therapeutic options in recurrent stroke/TIA prevention. Useful features include treatment algorithms, illustrations, medication tables, charts and figures to enable both the specialist and the primary provider to ensure the best options to their patients in order to prevent the reocurrence of stroke/TIA.

Readership: Cardiology clinicians and primary care providers who deal with patients recovering from stroke/TIA
No recommended products at the moment.
No recommended products at the moment.